RBC Capital on Pliant Therapeutics (PLRX): 'we believe there was nothing concerning emerging from the call '

Go back to RBC Capital on Pliant Therapeutics (PLRX): 'we believe there was nothing concerning emerging from the call '

Form 8-K PLIANT THERAPEUTICS, For: Jul 10

July 11, 2022 7:01 AM EDT

Exhibit 99.1

 

Pliant Therapeutics Announces Positive Safety and Efficacy Data from Phase 2a INTEGRIS-IPF Clinical Trial of... More